BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND KMT2D, ENSG00000167548, 8085, MLL2 AND Treatment
15 results:

  • 1. Clinicopathological characteristics, molecular landscape, and biomarker landscape for predicting the efficacy of PD-1/PD-L1 inhibitors in Chinese population with mismatch repair deficient urothelial carcinoma: a real-world study.
    Ma YT; Hua F; Zhong XM; Xue YJ; Li J; Nie YC; Zhang XD; Ma JW; Lin CH; Zhang HZ; He W; Sha D; Zhao MQ; Yao ZG
    Front Immunol; 2023; 14():1269097. PubMed ID: 38022513
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Pucotenlimab in patients with advanced mismatch repair-deficient or microsatellite instability-high solid tumors: A multicenter phase 2 study.
    Zhang B; Song Y; Luo S; Yin X; Li E; Wang H; He Y; Liu Z; Fan Q; Liang X; Shu Y; Liu Y; Xu N; Zhang S; Zhuang Z; Zhang J; Kou X; Wang F; Zhu X; Zeng S; Wang K; Zhong H; Li S; Bai Y; Yu J; Dou Y; Ma T; Liu Q; Huang J
    Cell Rep Med; 2023 Dec; 4(12):101301. PubMed ID: 38016482
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. An antibody-drug conjugate targeting GPR56 demonstrates efficacy in preclinical models of colorectal cancer.
    Jacob J; Francisco LE; Chatterjee T; Liang Z; Subramanian S; Liu QJ; Rowe JH; Carmon KS
    Br J Cancer; 2023 Apr; 128(8):1592-1602. PubMed ID: 36759728
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of KMT2C/D loss-of-function variants with response to immune checkpoint blockades in colorectal cancer.
    Liu R; Niu Y; Liu C; Zhang X; Zhang J; Shi M; Zou W; Gu B; Zhu H; Wang D; Yuan H; Li W; Zhao D; Zheng Q; Liu R; Chen W; Ma T; Zhang Y
    Cancer Sci; 2023 Apr; 114(4):1229-1239. PubMed ID: 36601880
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. BET Inhibitors Induce p53-Independent Growth Arrest in HCT116 Cells via Epigenetic Control of the E2F1/c-MYC Axis.
    Jeon D; Kim N; Um SJ
    Biol Pharm Bull; 2023; 46(1):12-18. PubMed ID: 36596519
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Surgical treatment of digestive cancer in a well-defined elderly population.
    Latrille A; Bouvier AM; Jooste V; Bengrine Lefevre L; Quipourt V; Moreno Lopez N; Facy O
    Clin Res Hepatol Gastroenterol; 2022 Mar; 46(3):101857. PubMed ID: 34963649
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Molecular Analyses of Left- and Right-Sided Tumors in Adolescents and Young Adults with colorectal cancer.
    Salem ME; Battaglin F; Goldberg RM; Puccini A; Shields AF; Arguello D; Korn WM; Marshall JL; Grothey A; Lenz HJ
    Oncologist; 2020 May; 25(5):404-413. PubMed ID: 31848314
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. FOLFCIS treatment and Genomic Correlates of Response in Advanced Anal Squamous Cell cancer.
    Mondaca S; Chatila WK; Bates D; Hechtman JF; Cercek A; Segal NH; Stadler ZK; Varghese AM; Kundra R; Capanu M; Shia J; Schultz N; Saltz L; Yaeger R
    Clin Colorectal Cancer; 2019 Mar; 18(1):e39-e52. PubMed ID: 30316684
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Impact of Patient Age on Molecular Alterations of Left-Sided colorectal Tumors.
    Puccini A; Lenz HJ; Marshall JL; Arguello D; Raghavan D; Korn WM; Weinberg BA; Poorman K; Heeke AL; Philip PA; Shields AF; Goldberg RM; Salem ME
    Oncologist; 2019 Mar; 24(3):319-326. PubMed ID: 30018131
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Comprehensive Genomic Profiling of Metastatic Squamous Cell Carcinoma of the Anal Canal.
    Morris V; Rao X; Pickering C; Foo WC; Rashid A; Eterovic K; Kim T; Chen K; Wang J; Shaw K; Eng C
    Mol Cancer Res; 2017 Nov; 15(11):1542-1550. PubMed ID: 28784613
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chromosomal abnormalities and molecular landscape of metastasizing mucinous salivary adenocarcinoma.
    Panaccione A; Zhang Y; Mi Y; Mitani Y; Yan G; Prasad ML; McDonald WH; El-Naggar AK; Yarbrough WG; Ivanov SV
    Oral Oncol; 2017 Mar; 66():38-45. PubMed ID: 28249646
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Complications and risk prediction in treatment of elderly patients with rectal cancer.
    Stornes T; Wibe A; Endreseth BH
    Int J Colorectal Dis; 2016 Jan; 31(1):87-93. PubMed ID: 26298183
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. [Rectum carcinoma. Optimizing therapy by deep resection or excision].
    Bruch HP; Roblick UJ; Schwandner O
    Zentralbl Chir; 1999; 124(5):422-7. PubMed ID: 10420529
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. [Surgical standards in rectal cancer].
    Köckerling F; Gall FP
    Chirurg; 1994 Jul; 65(7):593-603. PubMed ID: 7924597
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. 9-Deazaadenosine. Cytocidal activity and effects on nucleic acids and protein synthesis in human colon carcinoma cells in culture.
    Glazer RI; Hartman KD; Knode MC
    Mol Pharmacol; 1983 Sep; 24(2):309-15. PubMed ID: 6888372
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.